YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[robotic financial intelligence platform visualizing cross market volatility and predictive trading behavior] Stock futures edged higher Thursday as markets kick off Q4 trading following a volatile September, supported by steady Treasury y…
SAN DIEGO, September 10, 2026--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein…
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen concentrator (POC) space. The optimism, led by a diversified and expanding product portfolio, strong momentum in internatio…
IDEXX Laboratories IDXX is balancing durable diagnostic growth, improving profitability and a broad innovation cycle against a valuation that remains well above major benchmarks. The operating picture is favorable, but the stock still requ…
On August 6, Inogen (NASDAQ:INGN) reported second-quarter results that captured the company's split personality right now. International sales keep compounding, new products are finding buyers, and profitability is improving. But the US bu…
Inogen, Inc. INGN lowered its 2026 revenue outlook after second-quarter results showed continued U.S. channel pressure despite better profitability and international growth. The revision puts more focus on how quickly the company can adapt…
Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based…
Inogen, Inc. INGN reported breakeven earnings for second-quarter 2026, compared to the year-ago period's adjusted loss of 2 cents per share. GAAP loss per share of 14 cents, narrower than the year-ago loss of 15 cents. The figure beat the…
Key Points Interested in Inogen, Inc? Here are five stocks we like better. Second-quarter revenue rose 3% to $95.1 million, with international sales up 15% and new products helping offset a 2% decline in U.S. sales, particularly weakness i…
Smartbird, Inc. MKS Instruments director and former AWS executive to expand AI infrastructure firm's stewardship SAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Smartbird, Inc. (NASDAQ: BIRD), an AI infrastructure provider, today announce…
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen concentrator (POC) space. The optimism, led by a diversified and expanding product portfolio, strong momentum in internatio…
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen concentrator (POC) space. The optimism, led by a diversified and expanding product portfolio, strong momentum in internatio…
Inogen, Inc. INGN incurred an adjusted loss per share of 30 cents for first-quarter 2026, wider than the year-ago period’s adjusted loss of 25 cents per share. The Zacks Consensus Estimate was pinned at a loss of 24 cents per share. GAAP l…
Inogen logo Key Points Interested in Inogen, Inc? Here are five stocks we like better. Inogen reported Q1 revenue of $85.1 million (+3.4% YoY), with strong international growth (+18% to $37.7M) offsetting a 5% decline in U.S. sales as the…
Image source: The Motley Fool. Date Thursday, May 7, 2026 at 5 p.m. ET Call participants President and Chief Executive Officer — Kevin SmithChief Financial Officer — Jason RichardsonSenior Vice President, Investor Relations and Strategic P…
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen concentrator (POC) space. The optimism, led by a diversified and expanding product portfolio, strong momentum in internatio…
Inogen logo Key Points New CFO Jason Richardson — a 25-year MedTech veteran — joins Inogen as management adds a CMO and VP of U.S. B2B sales in a "deliberate realignment" aimed at accelerating top-line growth and margin expansion after two…
Inogen (INGN) shares ended the last trading session 6.9% higher at $6.8. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 'no gain, no loss' posit…
Inogen (INGN) shares ended the last trading session 6.9% higher at $6.8. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 'no gain, no loss' posit…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Anesthesia and Respiratory Devices Market size & share revenue was valued at approxima…
BEVERLY, Mass., April 06, 2026--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an indep…
Jason Richardson Named Chief Financial Officer, Succeeding Michael Bourque Dominic Hulton Named Chief Marketing Officer Corey Moritz Appointed Vice President, U.S. Business to Business Sales BEVERLY, Mass., March 30, 2026--(BUSINESS WIRE)-…
It has been about a month since the last earnings report for Veracyte (VCYT). Shares have lost about 15.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or…
Inogen logo Key Points CEO Kevin Smith says Inogen stabilized operations over the past two years, grew revenue about 10% and returned to positive adjusted EBITDA last year, putting the company in an “execution phase” toward profitable grow…
Inogen, Inc. INGN incurred an adjusted loss per share of 15 cents for fourth-quarter 2025, which was narrower than the adjusted loss per share of 24 cents in the year-ago period and the Zacks Consensus Estimate of a loss of 36 cents per sh…
Inogen, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Performance Drivers Achieved a strategic pivot from a single-product oxygen company to a diversified respiratory platform spanning oxygen, sleep therapy, airway…
Earnings Call Insights: Inogen (INGN) Q4 2025 MANAGEMENT VIEW * President and CEO Kevin Smith highlighted that "we delivered approximately $82 million in total revenue in the fourth quarter and nearly $349 million for the full year, reflec…
Inogen (INGN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items. This quarter…
Wall Street expects a year-over-year increase in earnings on higher revenues when Inogen (INGN) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings p…
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and a strong product portfolio, seems justi…
Idexx Laboratories (IDXX) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.62 per share a year ago. These figures are adjusted for non-recurring i…
Inogen, Inc. INGN has launched Aurora CPAP (continuous positive airway pressure) masks for Obstructive Sleep Apnea (OSA) in the United States yesterday. The FDA 510(k)-cleared mask is a new product within the company’s expanding portfolio.…
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and a strong product portfolio, seems justi…
Jacob Fund is a mutual fund company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The latest quarter showed continued market recovery, with major equity indexes reaching new all-time highs.…
It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 0.6% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading up…
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and a strong product portfolio, seems justi…